A Novel Missense Mutation in SRD5A3 Causes Congenital Disorder of Glycosylation Type I (Cerebello-Ocular Syndrome)

AUTOR(ES)

Al-Sarraj, Yasser

FONTE

J. inborn errors metab. screen.

DATA DE PUBLICAÇÃO

15/07/2019

RESUMO

Abstract A consanguineous Qatari family having an autosomal recessive disorder characterized by severe mental retardation, cerebellar vermis hypoplasia, retinal degeneration, optic nerve atrophy, ataxic gait, and seizures was studied for identification of the offending gene and mutation. Homozygosity mapping identified an 11.4 Mb critical interval at 4q12 to q13.2 that would contain the gene responsible for the disorder. Ten positional candidate genes were screened for pathogenic mutations, but none were identified. Next-generation exome sequencing in one affected individual identified a novel SRD5A3 missense mutation c.T744G/p.F248L, which was subsequently confirmed by Sanger sequencing, suggesting a congenital disorder of glycosylation type IQ defect. Isoelectric focusing of serum transferrin showed a type I pattern indicative of an .-glycan assembly defect. This is a novel pathogenic mutation and the first SRD5A3 missense mutation as all others are protein-truncating mutations.

Documentos Relacionados

• A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If)
• Deficiency of UDP-galactose:N-acetylglucosamine β-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId
• Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie
• MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If
• MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If